killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| immune response-regulating signaling pathway | ||
| immune response | ||
| natural killer cell mediated cytotoxicity |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| amyloid-beta binding | ||
| protein binding | ||
| HLA-B specific inhibitory MHC class I receptor activity | ||
| molecular adaptor activity |
| Gene Ontology |
|---|
| cell surface receptor signaling pathway |
| InterPro |
|---|
| Immunoglobulin-like domain superfamily |
| Immunoglobulin-like fold |
| Immunoglobulin |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12365 | malaria | |
| DOID:1883 | hepatitis C | |
| DOID:399 | tuberculosis | |
| DOID:526 | human immunodeficiency virus infectious disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025